Liyan Jiang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Tracheal and airway disorders
Papers in
-
- Lung Cancer Treatments and Mutations 49
- Lung Cancer Diagnosis and Treatment 18
- Co-authors
- Baohui Han (20 shared papers)Yizhuo Zhao (18 shared papers)Wenxin Qin (8 shared papers)Shaohua Cui (20 shared papers)Zhuoan Cheng (5 shared papers)Ping Gu (1 shared paper)Xin Yu (1 shared paper)Wei Zhang (1 shared paper)
- Journals
- Journal of Thoracic Oncology (8 papers)Journal of Clinical Oncology (7 papers)Journal of Cancer (4 papers)Annals of Oncology (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Liyan Jiang
138 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 905
- Molecular Biology 1.7k
- Otorhinolaryngology 79
Countries citing papers authored by Liyan Jiang
This map shows the geographic impact of Liyan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Jiang more than expected).
Fields of papers citing papers by Liyan Jiang
This network shows the impact of papers produced by Liyan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Jiang. The network helps show where Liyan Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyan Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis Hit paper breakdown → | 2009 | 436 |
| 2 | circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity Hit paper breakdown → | 2021 | 416 |
| 3 | 2019 | 284 | |
| 4 | 2018 | 195 | |
| 5 | 2017 | 138 | |
| 6 | 2016 | 99 | |
| 7 | 2019 | 88 | |
| 8 | 2018 | 83 | |
| 9 | 2013 | 78 | |
| 10 | 2011 | 74 | |
| 11 | 2021 | 68 | |
| 12 | 2016 | 66 | |
| 13 | 2021 | 64 | |
| 14 | 2016 | 61 | |
| 15 | 2012 | 56 | |
| 16 | 2019 | 52 | |
| 17 | 2021 | 49 | |
| 18 | 2020 | 47 | |
| 19 | 2014 | 44 | |
| 20 | 2020 | 41 |
About Liyan Jiang
Liyan Jiang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Spectroscopy, having authored 146 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (49 papers), Lung Cancer Research Studies (23 papers), Lung Cancer Diagnosis and Treatment (18 papers), Cancer Genomics and Diagnostics (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Mass Spectrometry Techniques and Applications (8 papers), Colorectal Cancer Treatments and Studies (8 papers) and Advanced Proteomics Techniques and Applications (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.4k citations), Oncology (905 citations), Molecular Biology (1.7k citations) and Otorhinolaryngology (79 citations). Liyan Jiang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Baohui Han, Yizhuo Zhao, Wenxin Qin, Shaohua Cui, Zhuoan Cheng, Ping Gu, Xin Yu, Wei Zhang, Shanqun Li and Zilong Liu. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Journal of Cancer, Annals of Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.